Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has informed the stock exchanges that its trading window will be closed for insiders, designated persons, and their immediate relatives starting Wednesday, October 01, 2025. The closure will remain in effect until 48 hours after the company declares its unaudited financial results for the quarter and half-year ended September 30, 2025. During this period, all such persons are prohibited from trading in the company's shares, including buying, selling, or pledging. The board meeting date to approve these results will be communicated separately. The filing is a routine compliance requirement under SEBI's insider trading regulations.
This is a standard regulatory filing and does not directly impact shareholders or the stock price. However, it signals that the company's Q2 FY26 financial results are expected to be announced soon, which investors should watch for as it may influence stock performance.